Recent Broad Publications
- Age- and Sex-Specific Causal Effects of Adiposity on Cardiovascular Risk Factors.
Read More / View Supplemental Materials - Commentary: Insights from across diagnostic boundaries: ADHD in the RDoC era - a commentary on Scerif and Baker ().
Read More / View Supplemental Materials - Searching for a minimal set of behaviors for autism detection through feature selection-based machine learning.
Read More / View Supplemental Materials - BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair.
Read More / View Supplemental Materials - Oncotator: Cancer Variant Annotation Tool.
Read More / View Supplemental Materials
Scientific Publications
< Back to Publications
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
| Publication Type | Journal Article |
| Authors | Saha, SK, Parachoniak CA, Ghanta KS, Fitamant J., Ross KN, Najem MS, Gurumurthy S., Akbay EA, Sia D., Cornella H., Miltiadous O., Walesky C., Deshpande V., Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J., Popovici-Muller J., Gliser C., Ferrone CR, Apte U., Llovet JM, Wong KK, Ramaswamy S., and Bardeesy N. |
| Abstract | Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are among the most common genetic alterations in intrahepatic cholangiocarcinoma (IHCC), a deadly liver cancer. Mutant IDH proteins in IHCC and other malignancies acquire an abnormal enzymatic activity allowing them to convert α-ketoglutarate (αKG) to 2-hydroxyglutarate (2HG), which inhibits the activity of multiple αKG-dependent dioxygenases, and results in alterations in cell differentiation, survival, and extracellular matrix maturation. However, the molecular pathways by which IDH mutations lead to tumour formation remain unclear. Here we show that mutant IDH blocks liver progenitor cells from undergoing hepatocyte differentiation through the production of 2HG and suppression of HNF-4α, a master regulator of hepatocyte identity and quiescence. Correspondingly, genetically engineered mouse models expressing mutant IDH in the adult liver show an aberrant response to hepatic injury, characterized by HNF-4α silencing, impaired hepatocyte differentiation, and markedly elevated levels of cell proliferation. Moreover, IDH and Kras mutations, genetic alterations that co-exist in a subset of human IHCCs, cooperate to drive the expansion of liver progenitor cells, development of premalignant biliary lesions, and progression to metastatic IHCC. These studies provide a functional link between IDH mutations, hepatic cell fate, and IHCC pathogenesis, and present a novel genetically engineered mouse model of IDH-driven malignancy. |
| Year of Publication | 2014 |
| Journal | Nature |
| Date Published (YYYY/MM/DD) | 2014/07/02 |
| ISSN Number | 0028-0836 |
| DOI | 10.1038/nature13441 |
| PubMed | http://www.ncbi.nlm.nih.gov/pubmed/25043045?dopt=Abstract |
Share This
- Tweet
